Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Pancreatic Neoplasms 24Breast Neoplasms 13Triple Negative Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Thymoma 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Nasopharyngeal Carcinoma 2Locally Advanced Pancreatic Cancer 2Borderline Resectable Pancreatic Cancer 2Biliary Tract Neoplasms 2Advanced Pancreatic Cancer 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Thromboembolism 1Thoracic Neoplasms 1Stage IV Gastric Cancer With Metastasis 1Stage IA Pancreatic Adenocarcinoma 1Squamous Cell Carcinoma of Lung 1Small Cell Lung Carcinoma 1Resectable Biliary Tract Cancer 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Muscle-Invasive Bladder Carcinoma 1Melanoma 1Lung Diseases 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Locally Advanced Cervical Carcinoma 1

Interventions

Cisplatin 51Gemcitabine 24Radiotherapy, Intensity-Modulated 21Docetaxel 20Fluorouracil 15camrelizumab 12Drug Therapy 11Radiotherapy 10toripalimab 8Chemoradiotherapy 8Capecitabine 8apatinib 7Induction Chemotherapy 7nimotuzumab 6endostar protein 6Endostatins 6sintilimab 5nedaplatin 5Bevacizumab 5fludarabine 4Cyclophosphamide 4spartalizumab 3fludarabine phosphate 3cisplatin-guanosine adduct 3SSRP1 protein, human 3Paclitaxel 3Injections 3Endoscopy 3tislelizumab 2Vitamin B 12 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Carcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT04282070 2021-12-21

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown
91 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04015661 2019-07-11

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC

Fuzhou General Hospital

Phase 2 Unknown
92 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡